Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Inventory (2025 - 2026)

Kura Oncology has reported Inventory over the past 2 years, most recently at $843000.0 for Q1 2026.

  • Quarterly Inventory changed N/A to $843000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $843000.0 through Mar 2026, changed N/A year-over-year, with the annual reading at $413000.0 for FY2025, N/A changed from the prior year.
  • Inventory was $843000.0 for Q1 2026 at Kura Oncology, up from $413000.0 in the prior quarter.
  • Over five years, Inventory peaked at $843000.0 in Q1 2026 and troughed at $413000.0 in Q4 2025.